Trazodone tablets, Apotex
50 mg, 100 count (NDC 60505-2653-01)
50 mg, 100 count, unit dose (NDC 60505-2653-00)
50 mg, 500 count (NDC 60505-2653-05)
100 mg, 100 count (NDC 60505-2654-01)
100 mg, 100 count, unit dose (NDC 60505-2654-00)
100 mg, 500 count (NDC 60505-2654-05)
150 mg, 100 count (NDC 6505-2655-01)
150 mg, 500 count (NDC 60505-2655-05)
300 mg, 100 count (NDC 60505-2659-01)
Trazodone tablets, Major
50 mg, 100 count, unit dose (NDC 00904-3990-61)
100 mg, 100 count, unit dose (NDC 00904-3991-61)
Trazodone tablets, Mutual
50 mg, 100 count (NDC 53489-0510-01)
100 mg, 100 count (NDC 53489-0511-01)
150 mg, 100 count (NDC 56489-0517-01)
Trazodone tablets, Mylan
50 mg, 1000 count (NDC 00378-3471-10)
150 mg, 100 count (NDC 00378-3473-01)
150 mg, 1000 count (NDC 00378-3473-10)
Trazodone tablets, Qualitest
50 mg, 100 count (NDC 00603-6160-21)
50 mg, 500 count (NDC 00603-6160-28)
50 mg, 1000 count (NDC 00603-6160-32)
100 mg, 100 count (NDC 00603-6161-21)
100 mg, 500 count (NDC 00603-6161-28)
100 mg, 1000 count (NDC 00603-6161-32)
Trazodone tablets, Teva
50 mg, 100 count (NDC 50111-0433-01)
50 mg, 100 count, unit dose (NDC 00182-1259-89)
50 mg, 500 count (NDC 50111-0433-02)
50 mg, 1000 count (NDC 50111-0433-03)
100 mg, 100 count (NDC 50111-0434-01)
100 mg, 100 count, unit dose (NDC 00182-1260-89)
100 mg, 500 count (NDC 50111-0434-02)
100 mg, 1000 count (NDC 50111-0434-03)
150 mg, 100 count (NDC 50111-0441-01)
150 mg, 500 count (NDC 50111-0441-02)
300 mg, 100 count (NDC 00555-0733-02)
July 2, 2012; April 25, 2012; April 17, 2012; March 23, 2012; March 9, 2012; February 8, 2012; January 27, 2012; January 4, 2012; December 20, 2011; November 7, 2011; October 19, 2011; September 29, 2011; September 15, 2011; August 11, 2011; July 6, 2011; June 13, 2011; April 20, 2011; March 30, 2011; March 7, 2011; February 2, 2011; January 13, 2011; December 16, 2010; November 24, 2010; October 29, 2010; October 1, 2010; September 16, 2010; September 7, 2010, University of Utah, Drug Information Service. Copyright 2012, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.